Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Xylocaine (Gel/Injection/Solution)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xylocaine 1% with Adrenaline 100microg/20ml inj vials
1502010J0BBAXAY
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | 7,414 |
|
Xylocaine 2% with Adrenaline 100microg/20ml inj vials
1502010J0BBA1A3
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | 2,888 |
|
Xylocaine 2% with Adrenaline 1 in 80,000 Dental inj 2.2ml
1502010J0BBBKCQ
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | 142 |
|
Xylocaine 0.5% with Adrenaline 100microg/20ml inj vials
1502010J0BBA3A7
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Xylocaine Topical 4% solution
1502010J0BBAMAK
|
Xylocaine (Gel/Injection/Solution) | Lidocaine hydrochloride | Anaesthesia | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.